Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · J.P. Morgan

JPMorgan Mid Cap Value Fund Class C (JCMVX)

Ticker JCMVX · · Holdings as of Jun 30, 2026

Expense ratio
1.54%$154/yr per $10k
5-yr return
+8.8%annualized
1-yr return
+3.0%as of Dec 2025
Net assets
$11.2Ball share classes
Holdings
105

Bottom line

Is JCMVX a good fund? The bottom line

JCMVX is the Class C share class of JPMorgan Mid Cap Value Fund, an actively managed mid-cap mutual fund from J.P. Morgan.

It charges 1.54% — about $154 a year on every $10,000 invested, more expensive than 88% of mid-cap funds we track.

It returned +3.0% over one year, +8.8% a year over five years, +7.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $11.2 billion in net assets and 105 holdings, its largest position is JPMorgan Prime Money Market Fund (4.3%) and the top 10 make up 20.2% of the portfolio.

What stands out

  • No front-end sales load
  • Large and established ($11.2 billion)

What to watch

  • Expensive for its category (1.54%)
  • 12b-1 marketing fee of 0.75% a year

Updated Nov 19, 2026

What JCMVX invests in

The Fund seeks growth from capital appreciation.

Under normal circumstances, the Fund invests at least 80% of its Assets in equity securities of mid cap value companies. Mid cap companies are companies with market capitalizations similar to those within the universe of the Russell Midcap Value Index at the time of purchase. As of September 30, 2026, the market capitalizations of the companies in the index ranged from approximately $1.76 billion to $251.62 billion. Value companies are those that the adviser believes are undervalued or attractively valued, based on one or more of the following factors: how the stock price compares to the companys sales, earnings, and assets, as well as the overall value of the company compared to its sales and the capital invested in it. Assets means net assets, plus the amount of borrowings for investment purposes. In implementing its main strategies, the Funds investments are primarily in common…

From the fund's prospectus (filed Oct 27, 2026).

JCMVX performance

Average annual total returns
1 yr5 yr10 yr
JCMVX+3.0%+8.8%+7.9%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full JCMVX performance history →

What JCMVX costs

On a $10,000 investment, JCMVX's 1.54% expense ratio costs about $154 a year. The prospectus estimates $1,860 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full JCMVX fee table →

JCMVX top 10 holdings

#Holding% of fund
1JPMorgan Prime Money Market Fund4.26%
2IQVIA Holdings, Inc.2.31%
3MKS, Inc.2.16%
4Silgan Holdings, Inc.1.76%
5Healthpeak Properties, Inc.1.73%
6AMETEK, Inc.1.71%
7Ameriprise Financial, Inc.1.61%
8M&T Bank Corp.1.60%
9First Citizens BancShares, Inc.1.52%
10Omnicom Group, Inc.1.50%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to JCMVX

More funds like JCMVX →

JCMVX FAQ

What is the expense ratio of JCMVX?
JCMVX's expense ratio is 1.54%, which works out to about $154 a year for every $10,000 invested. The prospectus estimates total costs of $1,860 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JCMVX a good investment?
It depends on your goals, but the data points to: no front-end sales load; large and established ($11.2 billion); expensive for its category (1.54%); 12b-1 marketing fee of 0.75% a year. This is general information, not personalized advice.
What does JCMVX hold?
JCMVX's largest holdings are JPMorgan Prime Money Market Fund (4.3%), IQVIA Holdings, Inc. (2.3%), MKS, Inc. (2.2%), Silgan Holdings, Inc. (1.8%), Healthpeak Properties, Inc. (1.7%). It holds 105 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is JCMVX's 5-year return?
JCMVX returned +8.8% a year over the five years ending Dec 31, 2025, and +7.9% a year over ten years. Past performance does not guarantee future results.
Does JCMVX have a sales load?
No. JCMVX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages JCMVX?
JCMVX is offered by J.P. Morgan through Jp Morgan Fleming Mutual Fund Group Inc.